Iranian Journal of Pediatrics

Published by: Kowsar

Evaluating the Effect of High Dose Versus Low Dose Heparin in Peripherally Inserted Central Catheter in Very Low Birth Weight Infants

Behzad Barekatain 1 , Amir Mohammad Armanian 2 , Ladan Salamaty 2 , * , Armindokht Shahsanai 3 and Ali Safaei 4
Authors Information
1 Department of Pediatrics, Division of Neonatology, Child Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Pediatrics, Division of Neonatology, Isfahan University of Medical Sciences, Isfahan, Iran
3 Department of Social Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
4 Student of Medical Sciences, Isfahan University of Medical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
Article information
  • Iranian Journal of Pediatrics: June 2018, 28 (3); e60800
  • Published Online: March 11, 2018
  • Article Type: Research Article
  • Received: August 23, 2017
  • Revised: October 20, 2017
  • Accepted: February 20, 2018
  • DOI: 10.5812/ijp.60800

To Cite: Barekatain B, Armanian A M, Salamaty L, Shahsanai A, Safaei A. Evaluating the Effect of High Dose Versus Low Dose Heparin in Peripherally Inserted Central Catheter in Very Low Birth Weight Infants, Iran J Pediatr. 2018 ; 28(3):e60800. doi: 10.5812/ijp.60800.

Copyright © 2018, Iranian Journal of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Chathas MK, Paton JB, Fisher DE. Percutaneous central venous catheterization. Three years' experience in a neonatal intensive care unit. Am J Dis Child. 1990;144(11):1246-50. [PubMed: 2239866].
  • 2. Sketch MH, Cale M, Mohiuddin SM, Booth RW. Use of percutaneously inserted venous catheters in coronary care units. Chest. 1972;62(6):684-9. doi: 10.1378/chest.62.6.684. [PubMed: 4635417].
  • 3. Mahieu LM, De Muynck AO, Ieven MM, De Dooy JJ, Goossens HJ, Van Reempts PJ. Risk factors for central vascular catheter-associated bloodstream infections among patients in a neonatal intensive care unit. J Hosp Infect. 2001;48(2):108-16. doi: 10.1053/jhin.2001.0984. [PubMed: 11428877].
  • 4. Aggarwal R, Downe L. Use of percutaneous silastic central venous catheters in the management of newborn infants. Indian Pediatr. 2001;38(8):889-92. [PubMed: 11521000].
  • 5. Moureau N. Neonatal and pediatric peripherally inserted central catheters basic manual. Ecouen, France: VYGON Corporation; 2005.
  • 6. Kamala F, Boo NY, Cheah FC, Birinder K. Randomized controlled trial of heparin for prevention of blockage of peripherally inserted central catheters in neonates. Acta Paediatr. 2002;91(12):1350-6. doi: 10.1111/j.1651-2227.2002.tb02833.x. [PubMed: 12578294].
  • 7. Moclair A, Bates I. The efficacy of heparin in maintaining peripheral infusions in neonates. Eur J Pediatr. 1995;154(7):567-70. doi: 10.1007/BF02074836. [PubMed: 7556325].
  • 8. Appelgren P, Ransjo U, Bindslev L, Espersen F, Larm O. Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: results from a prospective, randomized trial. Crit Care Med. 1996;24(9):1482-9. doi: 10.1097/00003246-199609000-00009. [PubMed: 8797619].
  • 9. Upadhyay A, Verma KK, Lal P, Chawla D, Sreenivas V. Heparin for prolonging peripheral intravenous catheter use in neonates: a randomized controlled trial. J Perinatol. 2015;35(4):274-7. doi: 10.1038/jp.2014.203. [PubMed: 25474552].
  • 10. Betremieux P, Odent S, Prigent J. Study of continuous infusion of low doses of heparin in the prevention of complications of catheters during the neonatal period. Rev Pediatr. 1988;7:311-5.
  • 11. Chang GY, Lueder FL, DiMichele DM, Radkowski MA, McWilliams LJ, Jansen RD. Heparin and the risk of intraventricular hemorrhage in premature infants. J Pediatr. 1997;131(3):362-6. doi: 10.1016/S0022-3476(97)80059-5. [PubMed: 9329410].
  • 12. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995;332(20):1330-5. doi: 10.1056/NEJM199505183322003. [PubMed: 7715641].
  • 13. Malloy MH, Cutter GR. The association of heparin exposure with intraventricular hemorrhage among very low birth weight infants. J Perinatol. 1995;15(3):185-91. [PubMed: 7666265].
  • 14. Lesko SM, Mitchell AA, Epstein MF, Louik C, Giacoia GP, Shapiro S. Heparin use as a risk factor for intraventricular hemorrhage in low-birth-weight infants. N Engl J Med. 1986;314(18):1156-60. doi: 10.1056/NEJM198605013141805. [PubMed: 3960090].
  • 15. Monagle P, Chan AKC, Goldenberg NA, Ichord RN, Journeycake JM, Nowak-Gottl U, et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e737S-801S. doi: 10.1378/chest.11-2308. [PubMed: 22315277].
  • 16. Shah PS, Ng E, Sinha AK. Heparin for prolonging peripheral intravenous catheter use in neonates. Cochrane Database Syst Rev. 2002;(4). CD002774. doi: 10.1002/14651858.CD002774. [PubMed: 12519576].
  • 17. Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials. BMJ. 1998;316(7136):969-75. doi: 10.1136/bmj.316.7136.969. [PubMed: 9550955].
  • 18. Shah PS, Kalyn A, Satodia P, Dunn MS, Parvez B, Daneman A, et al. A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (Heparin Infusion for PCVC) study. Pediatrics. 2007;119(1):e284-91. doi: 10.1542/peds.2006-0529. [PubMed: 17200252].
  • 19. Ankola PA, Atakent YS. Effect of adding heparin in very low concentration to the infusate to prolong the patency of umbilical artery catheters. Am J Perinatol. 1993;10(3):229-32. doi: 10.1055/s-2007-994726. [PubMed: 8517902].
  • 20. Blauhut B, Necek S, Kramar H, Vinazzer H, Bergmann H. Activity of antithrombin III and effect of heparin on coagulation in shock. Thromb Res. 1980;19(6):775-82. [PubMed: 7466746].
  • 21. Rennie JM, Kendall G. A Manual of Neonatal Intensive Care. Fifth ed. CRC Press; 2013.

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments